Aquestive Therapeutics, Inc.
AQST· Nasdaq
AQSTAquestive Therapeutics, Inc.
Filed May 8, 2019 · 10-Q · 38 days after period end · 0001140361-19-008649
| Metric | Q1 2019 | Q1 2018 | Q1 2017 |
|---|---|---|---|
| Revenue | $12.64M | $23.41M | $16.44M |
| Net Income | -$14.73M | $4.10M | -$1.46M |
| EPS Diluted | -$0.59 | $0.27 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Aquestive Therapeutics, Inc. · CIK 1398733 · Engraved from SEC EDGAR
ended Mar 31, 2019 · filed May 8, 2019 · 38 d after period end
